Atara Biotherapeutics Inc Major Shareholders & Ownership History
| Major Shareholder Name | Reporting Date | Shares Held | Market Value | Change in Shares | Ownership |
|---|---|---|---|---|---|
| ADAGE CAPITAL PARTNERS GP, L.L.C. | 05/15/2026 | 700.00 K | $3.31 M | 100.00% | 5.58% |
| REDMILE GROUP, LLC | 05/15/2026 | 441.70 K | $2.09 M | 0.00% | 3.52% |
| MACKENZIE FINANCIAL CORP | 05/13/2026 | 313.62 K | $1.48 M | 434.57% | 2.50% |
| 05/15/2026 | 217.86 K | $1.03 M | 100.00% | 1.74% | |
| POINT72 ASSET MANAGEMENT, L.P. | 05/15/2026 | 194.26 K | $918.87 K | 961.78% | 1.55% |
| ACADIAN ASSET MANAGEMENT LLC | 05/13/2026 | 130.91 K | $617.00 K | 142.21% | 1.04% |
| ECOR1 CAPITAL, LLC | 05/15/2026 | 99.59 K | $471.08 K | -82.62% | 0.79% |
| BLACKROCK, INC. | 05/13/2026 | 79.02 K | $373.77 K | 17.75% | 0.63% |
| GEODE CAPITAL MANAGEMENT, LLC | 05/15/2026 | 66.15 K | $313.05 K | 6.04% | 0.53% |
| UBS GROUP AG | 05/05/2026 | 50.07 K | $236.83 K | 3,484.11% | 0.40% |
| STALEY CAPITAL ADVISERS INC | 04/29/2026 | 50.00 K | $236.50 K | 0.00% | 0.40% |
| MILLENNIUM MANAGEMENT LLC | 05/15/2026 | 47.69 K | $225.57 K | 100.00% | 0.38% |
| JANE STREET GROUP, LLC | 05/12/2026 | 33.87 K | $160.21 K | 142.10% | 0.27% |
| VANGUARD FIDUCIARY TRUST CO | 05/08/2026 | 33.62 K | $159.03 K | 100.00% | 0.27% |
| BRIDGEWAY CAPITAL MANAGEMENT, LLC | 05/15/2026 | 32.69 K | $154.63 K | 0.00% | 0.26% |
| STATE STREET CORP | 05/15/2026 | 26.45 K | $125.12 K | 0.00% | 0.21% |
| FMR LLC | 05/15/2026 | 16.24 K | $76.81 K | -5.35% | 0.13% |
| NORTHERN TRUST CORP | 05/14/2026 | 12.34 K | $58.37 K | 0.00% | 0.10% |
| MORGAN STANLEY | 05/15/2026 | 9.17 K | $43.37 K | -42.66% | 0.07% |
| ROYAL BANK OF CANADA | 05/15/2026 | 4.32 K | $20.00 K | 408.12% | 0.03% |
| SBI SECURITIES CO., LTD. | 04/28/2026 | 1.57 K | $7.45 K | 12.11% | 0.01% |
| VANGUARD GLOBAL ADVISERS, LLC | 05/08/2026 | 1.46 K | $6.89 K | 100.00% | 0.01% |
| JONES FINANCIAL COMPANIES LLLP | 05/15/2026 | 703 | $3.23 K | 0.00% | 0.01% |
| WELLS FARGO & COMPANY/MN | 05/11/2026 | 251 | $1.19 K | 0.00% | 0.00% |
| JPMORGAN CHASE & CO | 05/13/2026 | 216 | $933 | 0.00% | 0.00% |
| RAIFFEISEN BANK INTERNATIONAL AG | 04/24/2026 | 200 | $946 | 0.00% | 0.00% |
| BANQUE TRANSATLANTIQUE SA | 05/13/2026 | 176 | $906 | 0.00% | 0.00% |
| RHUMBLINE ADVISERS | 05/12/2026 | 175 | $827 | 0.00% | 0.00% |
| BNP PARIBAS ARBITRAGE, SNC | 05/12/2026 | 58 | $274 | 26.09% | 0.00% |
| 04/29/2026 | 24 | $116 | 0.00% | 0.00% | |
| ADVISOR GROUP HOLDINGS, INC. | 05/15/2026 | 10 | $47 | 0.00% | 0.00% |
| ROCKEFELLER CAPITAL MANAGEMENT L.P. | 05/14/2026 | 8 | $38 | 0.00% | 0.00% |
| CITIGROUP INC | 05/11/2026 | 1 | $5 | 100.00% | 0.00% |
| WESTERN WEALTH MANAGEMENT, LLC | 05/19/2026 | 1 | $5 | 100.00% | 0.00% |
| BANK OF AMERICA CORP /DE/ | 05/18/2026 | 0 | $0 | -100.00% | 0.00% |
| DIMENSIONAL FUND ADVISORS LP | 05/07/2026 | 0 | $0 | -100.00% | 0.00% |
| GLOBEFLEX CAPITAL L P | 05/13/2026 | 0 | $0 | -100.00% | 0.00% |
| RENAISSANCE TECHNOLOGIES LLC | 05/14/2026 | 0 | $0 | -100.00% | 0.00% |
| FEDERATED HERMES, INC. | 05/11/2026 | 0 | $0 | -100.00% | 0.00% |
| MARSHALL WACE, LLP | 05/15/2026 | 0 | $0 | -100.00% | 0.00% |
| CAMBRIDGE INVESTMENT RESEARCH ADVISORS, INC. | 04/30/2026 | 0 | $0 | -100.00% | 0.00% |
| CITADEL ADVISORS LLC | 05/15/2026 | 0 | $0 | -100.00% | 0.00% |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | 05/15/2026 | 0 | $0 | -100.00% | 0.00% |
| TOWER RESEARCH CAPITAL LLC (TRC) | 05/15/2026 | 0 | $0 | -100.00% | 0.00% |
| CONNOR, CLARK & LUNN INVESTMENT MANAGEMENT LTD. | 05/11/2026 | 0 | $0 | -100.00% | 0.00% |
| QUADRATURE CAPITAL LTD | 05/15/2026 | 0 | $0 | -100.00% | 0.00% |
| WALLEYE CAPITAL LLC | 05/13/2026 | 0 | $0 | -100.00% | 0.00% |
| PRIVATE WEALTH ASSET MANAGEMENT, LLC | 05/06/2026 | 0 | $0 | -100.00% | 0.00% |
Explore Related Stocks for Market Trends
Explore our related stocks for the latest market trends and stock news to stay informed and make better decisions.
Atara Biotherapeutics Inc institutional Ownership - FAQ's
During the previous two years, 82 institutional investors and hedge funds held shares of Atara Biotherapeutics Inc. The most heavily invested institutionals were:
ADAGE CAPITAL PARTNERS GP, L.L.C.: 700,000
Redmile Group, LLC: 441,701
MACKENZIE FINANCIAL CORP: 313,620
Point72 Asset Management, L.P.: 194,264
ACADIAN ASSET MANAGEMENT LLC: 130,910
EcoR1 Capital, LLC: 99,593
20.44% of Atara Biotherapeutics Inc stock is owned by institutional investors.
Institutional investors have bought a total of 7.69 M shares in the last 24 months. This purchase volume represents approximately $51.35 M in transactions.